Go Pro
→ Are you leaving Social Security money on the table? (From Money Pickle) (Ad)tc pixel Free GMVDF Stock Alerts

G Medical Innovations (GMVDF) Competitors

Compare

GMVDF vs. SDCCQ, SSKN, TTOO, VRAYQ, and AFIB

Should you buy G Medical Innovations stock or one of its competitors? G Medical Innovations's main competitors and comparable companies include SmileDirectClub (SDCCQ), Strata Skin Sciences (SSKN), T2 Biosystems (TTOO), ViewRay (VRAYQ), and Acutus Medical (AFIB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does G Medical Innovations compare to SmileDirectClub?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 64.7% of SmileDirectClub shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

G Medical Innovations has a beta of 28.73, indicating that its share price is 2,773% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, indicating that its share price is 31% more volatile than the broader market.

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to Strata Skin Sciences?

Strata Skin Sciences (NASDAQ:SSKN) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

Given G Medical Innovations' higher possible upside, analysts plainly believe G Medical Innovations is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
G Medical Innovations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 37.1% of G Medical Innovations shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

G Medical Innovations has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. G Medical Innovations' return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
G Medical Innovations N/A N/A N/A

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
Strata Skin Sciences Neutral
G Medical Innovations Neutral

Strata Skin Sciences has a beta of 0.04, suggesting that its stock price is 96% less volatile than the broader market. Comparatively, G Medical Innovations has a beta of 28.73, suggesting that its stock price is 2,773% more volatile than the broader market.

Strata Skin Sciences has higher revenue and earnings than G Medical Innovations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Summary

Strata Skin Sciences and G Medical Innovations tied by winning 5 of the 10 factors compared between the two stocks.

How does G Medical Innovations compare to T2 Biosystems?

T2 Biosystems (NASDAQ:TTOO) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

G Medical Innovations has lower revenue, but higher earnings than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

In the previous week, T2 Biosystems' average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
T2 Biosystems Neutral
G Medical Innovations Neutral

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
G Medical Innovations N/A N/A N/A

23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

T2 Biosystems has a beta of 7.75, indicating that its stock price is 675% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 28.73, indicating that its stock price is 2,773% more volatile than the broader market.

Summary

G Medical Innovations beats T2 Biosystems on 5 of the 7 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

In the previous week, ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
ViewRay Neutral
G Medical Innovations Neutral

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
G Medical Innovations N/A N/A N/A

G Medical Innovations has lower revenue, but higher earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33MN/AN/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

ViewRay has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, G Medical Innovations has a beta of 28.73, meaning that its stock price is 2,773% more volatile than the broader market.

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

G Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

G Medical Innovations (NASDAQ:GMVDF) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Acutus Medical Neutral

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

G Medical Innovations has a beta of 28.73, meaning that its stock price is 2,773% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, meaning that its stock price is 473% more volatile than the broader market.

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

G Medical Innovations has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Summary

G Medical Innovations beats Acutus Medical on 6 of the 8 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDF vs. The Competition

Export
MetricG Medical InnovationsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$26K$5.81B$7.26B$12.73B
Dividend YieldN/A1.76%2.53%8.86%
P/E RatioN/A25.92273.2925.38
Price / SalesN/A73.28613.4597.56
Price / CashN/A33.1477.8252.26
Price / BookN/A6.0412.896.14
Net Income-$24.63M$150.03M$3.47B$349.01M

G Medical Innovations Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
SSKN
Strata Skin Sciences
N/A$0.01
flat		N/A-99.7%$29K$30.98MN/A120
TTOO
T2 Biosystems
N/A$0.00
+66.7%		N/A-76.2%$21K$7.68MN/A180
VRAYQ
ViewRay
N/AN/AN/AN/A$16K$102.21MN/A300

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
In 1984, a 10000 dollar stake in Apple could have grown to 25 million dollars for early investors who simply g...
Eagle Publishing | Sponsoredtc pixel